Frank T. Watkins - 20 Jul 2022 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Frank T. Watkins
Issuer symbol
N/A
Transactions as of
20 Jul 2022
Net transactions value
-$619,322
Form type
4
Filing time
21 Jul 2022, 20:35:21 UTC
Previous filing
27 Jun 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Sale $54,471 -267 -1.4% $204.01 18,529 20 Jul 2022 Direct F1, F2
transaction SWAV Common Stock Sale $191,517 -933 -5% $205.27 17,596 20 Jul 2022 Direct F1, F3
transaction SWAV Common Stock Sale $331,696 -1,600 -9.1% $207.31 15,996 20 Jul 2022 Direct F1, F4
transaction SWAV Common Stock Sale $41,638 -200 -1.3% $208.19 15,796 20 Jul 2022 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 12/1/2021.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.01 to $204.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.12 to $206.03. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.05 to $208.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 All reported securities were sold at a price of $208.19.